Northwestern Mutual Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,719
Closed -$500K 3345
2021
Q2
$500K Sell
2,719
-484
-15% -$89K ﹤0.01% 982
2021
Q1
$490K Sell
3,203
-553
-15% -$84.6K ﹤0.01% 929
2020
Q4
$587K Buy
3,756
+159
+4% +$24.8K ﹤0.01% 788
2020
Q3
$412K Buy
3,597
+218
+6% +$25K ﹤0.01% 804
2020
Q2
$380K Buy
3,379
+818
+32% +$92K ﹤0.01% 774
2020
Q1
$229K Buy
2,561
+361
+16% +$32.3K ﹤0.01% 841
2019
Q4
$237K Sell
2,200
-191
-8% -$20.6K ﹤0.01% 887
2019
Q3
$234K Sell
2,391
-1,225
-34% -$120K ﹤0.01% 836
2019
Q2
$474K Buy
3,616
+417
+13% +$54.7K ﹤0.01% 642
2019
Q1
$432K Buy
3,199
+214
+7% +$28.9K ﹤0.01% 665
2018
Q4
$291K Sell
2,985
-239
-7% -$23.3K ﹤0.01% 698
2018
Q3
$448K Buy
3,224
+109
+3% +$15.1K ﹤0.01% 591
2018
Q2
$386K Sell
3,115
-97
-3% -$12K ﹤0.01% 595
2018
Q1
$358K Buy
3,212
+332
+12% +$37K ﹤0.01% 585
2017
Q4
$344K Sell
2,880
-442
-13% -$52.8K ﹤0.01% 587
2017
Q3
$467K Sell
3,322
-182
-5% -$25.6K ﹤0.01% 496
2017
Q2
$426K Buy
3,504
+277
+9% +$33.7K ﹤0.01% 510
2017
Q1
$391K Sell
3,227
-970
-23% -$118K ﹤0.01% 506
2016
Q4
$514K Buy
+4,197
New +$514K 0.01% 448
2016
Q3
Sell
-3,483
Closed -$407K 1719
2016
Q2
$407K Sell
3,483
-128
-4% -$15K 0.01% 443
2016
Q1
$503K Buy
3,611
+1,321
+58% +$184K 0.01% 388
2015
Q4
$437K Sell
2,290
-171
-7% -$32.6K 0.01% 370
2015
Q3
$385K Sell
2,461
-163
-6% -$25.5K 0.01% 376
2015
Q2
$475K Sell
2,624
-7
-0.3% -$1.27K 0.01% 331
2015
Q1
$456K Buy
2,631
+437
+20% +$75.7K 0.01% 332
2014
Q4
$406K Buy
2,194
+276
+14% +$51.1K 0.01% 327
2014
Q3
$318K Sell
1,918
-173
-8% -$28.7K 0.01% 347
2014
Q2
$327K Buy
2,091
+151
+8% +$23.6K 0.01% 323
2014
Q1
$295K Buy
1,940
+83
+4% +$12.6K 0.01% 334
2013
Q4
$246K Buy
1,857
+11
+0.6% +$1.46K 0.01% 353
2013
Q3
$215K Buy
1,846
+192
+12% +$22.4K 0.01% 342
2013
Q2
$153K Buy
+1,654
New +$153K 0.01% 375